175 related articles for article (PubMed ID: 2332269)
21. Psammoma bodies in Papanicolaou tests and associated factors to predict an underlying malignancy: a clinicopathological analysis of 10 cases.
Ersoy E; Kashikar RM
J Am Soc Cytopathol; 2020; 9(4):266-271. PubMed ID: 32376242
[TBL] [Abstract][Full Text] [Related]
22. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases.
Zhou C; Gilks CB; Hayes M; Clement PB
Am J Surg Pathol; 1998 Jan; 22(1):113-20. PubMed ID: 9422324
[TBL] [Abstract][Full Text] [Related]
23. Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature.
Bodnar L; Wcislo G; Górnas M; Gasowska-Bodnar A; Wiśniewski P; Stec R; Baranowski W; Szczylik C
Ginekol Pol; 2009 Aug; 80(8):632-6. PubMed ID: 19824465
[TBL] [Abstract][Full Text] [Related]
24. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
[TBL] [Abstract][Full Text] [Related]
25. Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma.
Jena SK; Mishra P; Mohapatra V; Singh S
Case Rep Obstet Gynecol; 2015; 2015():531242. PubMed ID: 26557397
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of primary papillary peritoneal neoplasia in patients with ovarian carcinoma.
Lindeque BG; Cronjé HS; Deale CJ
S Afr Med J; 1985 Jun; 67(25):1005-7. PubMed ID: 4012463
[TBL] [Abstract][Full Text] [Related]
27. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
Sangoi AR; Soslow RA; Teng NN; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
[TBL] [Abstract][Full Text] [Related]
28. Serous psammocarcinoma of the ovary: a case report and review of literature.
Giordano G; Gnetti L; Milione M; Piccolo D; Soliani P
Gynecol Oncol; 2005 Jan; 96(1):259-62. PubMed ID: 15589614
[TBL] [Abstract][Full Text] [Related]
29. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.
Ahn G; Folkins AK; McKenney JK; Longacre TA
Am J Surg Pathol; 2016 Sep; 40(9):1165-76. PubMed ID: 27487741
[TBL] [Abstract][Full Text] [Related]
30. Serous psammocarcinoma of the ovary in an adolescent female.
Kelley JL; Capelle SC; Kanbour-Shakir A
Gynecol Oncol; 1995 Nov; 59(2):309-11. PubMed ID: 7590493
[TBL] [Abstract][Full Text] [Related]
31. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
32. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'.
Lee KR; Scully RE
Am J Surg Pathol; 2000 Nov; 24(11):1447-64. PubMed ID: 11075847
[TBL] [Abstract][Full Text] [Related]
33. Case Report: Borderline tumor and primary peritoneal carcinoma - a rare synchronism.
Rei M; Raposo S; Figueiredo P; Sousa R; Sá L
F1000Res; 2019; 8():1630. PubMed ID: 31807285
[TBL] [Abstract][Full Text] [Related]
34. Peritoneal psammocarcinoma diagnosed by a Papanicolau smear: a case report.
Riboni F; Giana M; Piantanida P; Vigone A; Surico N; Boldorini R
Acta Cytol; 2010; 54(3):311-3. PubMed ID: 20518416
[TBL] [Abstract][Full Text] [Related]
35. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
[TBL] [Abstract][Full Text] [Related]
36. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
Baker PM; Oliva E; Young RH; Talerman A; Scully RE
Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
[TBL] [Abstract][Full Text] [Related]
37. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
38. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
39. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
[TBL] [Abstract][Full Text] [Related]
40. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
